{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:12:03Z","timestamp":1790223123197,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,1,1]],"date-time":"2006-01-01T00:00:00Z","timestamp":1136073600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1016\/j.contraception.2005.06.068","type":"journal-article","created":{"date-parts":[[2005,9,27]],"date-time":"2005-09-27T10:19:16Z","timestamp":1127816356000},"page":"34-40","source":"Crossref","is-referenced-by-count":37,"title":["The use of an oral contraceptive containing ethinylestradiol and drospirenone in an extended regimen over 126 days"],"prefix":"10.1016","volume":"73","author":[{"given":"Jean-Michel","family":"Foidart","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia J.","family":"Sulak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilka","family":"Schellschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doris","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2005.06.068_bib1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1126\/science.130.3367.81","article-title":"Effectiveness of an oral contraceptive; effects of a progestin\u2013estrogen combination upon fertility, menstrual phenomena, and health","volume":"130","author":"Pincus","year":"1959","journal-title":"Science"},{"key":"10.1016\/j.contraception.2005.06.068_bib2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S0140-6736(99)11159-0","article-title":"Nuisance or natural and healthy: should monthly menstruation be optional for women?","volume":"355","author":"Thomas","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2005.06.068_bib3","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/bmj.2.6085.487","article-title":"Acceptability of an oral contraceptive that reduces the frequency of menstruation: the tri-cycle pill regimen","volume":"2","author":"Loudon","year":"1977","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.06.068_bib4","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/bmj.320.7230.291","article-title":"Is norethisterone a lifestyle drug? Results of database analysis","volume":"320","author":"Shakespeare","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.contraception.2005.06.068_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0010-7824(03)00141-0","article-title":"A multicenter, randomized study of an extended cycle oral contraceptive","volume":"68","author":"Anderson","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.068_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0010-7824(02)00445-6","article-title":"Bleeding patterns and patient acceptability of standard or continuous dosing regimens of a low-dose oral contraceptive: a randomized trial","volume":"67","author":"Kwiecien","year":"2003","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.068_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0029-7844(03)00014-0","article-title":"Continuous combination oral contraceptive pills to eliminate withdrawal bleeding: a randomized trial","volume":"101","author":"Miller","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.06.068_bib8","article-title":"Drug approval package for Seasonale (levonorgestrel\/ethinyl estradiol) tablets","author":"U.S. Food and Drug Administration","year":"2004","journal-title":"Internet Commun"},{"key":"10.1016\/j.contraception.2005.06.068_bib9","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1067\/mob.2002.122988","article-title":"Acceptance of altering the standard 21-day\/7-day oral contraceptive regimen to delay menses and reduce hormone withdrawal symptoms","volume":"186","author":"Sulak","year":"2002","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.06.068_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.contraception.2004.04.007","article-title":"Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding","volume":"70","author":"Sulak","year":"2004","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.068_bib11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0010-7824(99)00043-8","article-title":"Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use","volume":"59","author":"den Tonkelaar","year":"1999","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.068_bib12","article-title":"Birth control guide","author":"U.S. Food and Drug Administration","year":"2004","journal-title":"FDA Consum"},{"key":"10.1016\/j.contraception.2005.06.068_bib13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1080\/13625180008500387","article-title":"A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel","volume":"5","author":"Foidart","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.06.068_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13625180008500375","article-title":"Efficacy and tolerability of a monophasic oral contraceptive containing ethinylestradiol and drospirenone","volume":"5","author":"Huber","year":"2000","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2005.06.068_bib15","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0010-7824(00)00083-4","article-title":"An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen","volume":"61","author":"Parsey","year":"2000","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.068_bib16","first-page":"123","article-title":"Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment","volume":"74","author":"Thorneycroft","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2005.06.068_bib17","first-page":"2","article-title":"The effect of 2 combined oral contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea","volume":"69","author":"van Vloten","year":"2002","journal-title":"Cutis"},{"key":"10.1016\/j.contraception.2005.06.068_bib18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2005.06.068_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/S0029-7844(96)00488-7","article-title":"Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms","volume":"89","author":"Sulak","year":"1997","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.06.068_bib20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0002-9378(99)70364-9","article-title":"The effects on ovarian activity of a monophasic oral contraceptive with 100 microg levonorgestrel and 20 microg ethinyl estradiol","volume":"181","author":"Coney","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2005.06.068_bib21","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/S0015-0282(01)01834-9","article-title":"Effect of a combined oral contraceptive containing 3 mg of drospirenone and 30 microg of ethinyl estradiol on the human endometrium","volume":"76","author":"Ludicke","year":"2001","journal-title":"Fertil Steril"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405002672?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782405002672?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T22:50:39Z","timestamp":1548111039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782405002672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["S0010782405002672"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2005.06.068","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}